Lorenzo, Cristina
Delgado, Pilar http://orcid.org/0000-0002-8431-8002
Busse, Christian E. http://orcid.org/0000-0001-7553-905X
Sanz-Bravo, Alejandro
Martos-Folgado, Inmaculada
Bonzon-Kulichenko, Elena
Ferrarini, Alessia http://orcid.org/0000-0002-4587-6095
Gonzalez-Valdes, Ileana B.
Mur, Sonia M.
Roldán-Montero, Raquel
Martinez-Lopez, Diego
Martin-Ventura, Jose L.
Vázquez, Jesús http://orcid.org/0000-0003-1461-5092
Wardemann, Hedda http://orcid.org/0000-0003-3921-5933
Ramiro, Almudena R. http://orcid.org/0000-0002-7539-3844
Article History
Received: 3 December 2019
Accepted: 5 October 2020
First Online: 2 December 2020
Competing interests
: An international patent application entitled “Antibodies for the diagnosis and/or treatment of atherosclerosis” (PCT/EP2020/076541) was filed by applicants Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) and German Cancer Research Center (DKFZ) on 24 September 2020, authored by A.R.R., C.L., H.W. and C.E.B., to protect the use of antibodies identified in this study. Status: pending. An international patent application entitled “Method for the diagnosis and/or treatment of atherosclerosis” (PCT/EP2020/076549) was filed by applicants: Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz and Universidad Autónoma de Madrid on 24 September 2020, authored by A.R.R., C.L., J.V., J.L.M.-V., A.S.-B., P.D. and E.B.-K., to protect the use of ALDH4A1 as an atherosclerosis biomarker. Status: pending.